anastrozole
Showing 26 - 50 of 171
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022
Breast Tumors, Breast Diseases Trial in New York (Anastrozole, Palbociclib, Trastuzumab)
Recruiting
- Breast Neoplasms
- Breast Diseases
- Anastrozole
- +3 more
-
New York, New York
- +4 more
Jun 25, 2021
Breast Cancer Trial in Bordeaux (anastrozole, fulvestrant)
Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)
Completed
- Metastatic Breast Cancer
- Paclitaxel
- +7 more
-
Chuo-ku, Nihonbashi, Koami-cho, Tokyo, JapanJapan Breast Cancer Research Group
Aug 2, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Abemaciclib
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)
Active, not recruiting
- Breast Cancer Metastatic
- Ribociclib
- +4 more
-
Ravensburg, GermanyStudienzentrum Onkologie Ravensburg
Mar 7, 2022
Breast Cancer Trial in Netherlands (Anastrozole, Anastrozole+Fulvestrant, Tamoxifen)
Suspended
- Breast Cancer
- Anastrozole
- +2 more
-
den Haag, ZH, Netherlands
- +3 more
Jan 20, 2021
Healthy Volunteers Trial in Barcelona (Bupropion, Anastrozole, Testosterone cyclopentylpropionate)
Completed
- Healthy Volunteers
- Bupropion
- +4 more
-
Barcelona, SpainIMIM (Hospital del Mar Medical Research Institute)
Apr 23, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,
Active, not recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Anastrozole
- +6 more
-
Atlanta, Georgia
- +9 more
Oct 12, 2022
Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)
Active, not recruiting
- Breast Cancer
- Invasive Breast Cancer
- Anastrozole
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital
Sep 16, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +13 more
- Anastrozole
- +9 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in
Terminated
- Estrogen Receptor-positive Breast Cancer
- +7 more
- everolimus
- +5 more
-
Atlanta, Georgia
- +2 more
Mar 10, 2022
Invasive Breast Cancer Trial in New York (Anastrozole)
Completed
- Invasive Breast Cancer
- Anastrozole
-
New York, New YorkColumbia University Medical Center
Jan 7, 2021
Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles
Recruiting
- Recurrent Endometrial Carcinoma
- +3 more
- Abemaciclib
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 28, 2021
ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant
Recruiting
- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Palbociclib 125Mg Tab
- +5 more
-
Christchurch, United Kingdom
- +3 more
May 19, 2022
Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)
Terminated
- Breast Neoplasm
- Palbociclib
- +4 more
-
Mainz, GermanyUniversity Hospital Mainz
Dec 16, 2021
Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)
Completed
- Solid Tumors
- Advanced Cancer
- Anastrozole
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 20, 2021
Sequence in HR+, HER2 - mBC in Moscow: A Multicenter
Recruiting
- Breast Cancer Stage IV
- Palbociclib
- +8 more
-
Moscow, Russian FederationN.N. Blokhin National Medical Research Center of Oncology
Apr 15, 2021
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- +4 more
-
Ijui, Rio Grande Do Sul, Brazil
- +44 more
Aug 8, 2022
Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)
Active, not recruiting
- Non Small Cell Lung Cancer
- Breast Cancer
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +22 more
Aug 8, 2022
ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, AZD9833 Placebo, Anastrozole)
Recruiting
- ER-Positive HER2-Negative Breast Cancer
- AZD9833
- +8 more
-
Phoenix, Arizona
- +215 more
Aug 4, 2022
Breast Cancer Trial in Netherlands (Anastrozole)
Unknown status
- Breast Cancer
- Anastrozole
-
Alkmaar, Netherlands
- +66 more
Aug 13, 2020